Abstract:Proteolysis-targeting chimeras (PROTACs) are a class of bifunctional molecules that can induce the ubiquitin degradation of its target protein by hijacking the E3 ligase to form a target protein-PROTAC-E3 ligase ternary complex. Its underlying principle has inspired the development of a wide range of protein degraders that are similar to or beyond PROTACs in recent years. The formation of the ternary complexes is the key to the success of PROTAC-induced protein degradation. Nevertheless, the lack of effective ternary complex modeling techniques has limited the application of computer-aided drug discovery tools to this emerging and fast developing new land in drug industry. Thus, in this study, we explored the application of the more physically sound molecular dynamics simulation and the molecular mechanics combined with the generalized Born and surface area continuum solvation (MM/GBSA) method to solve the underlying three-body problem in PROTAC modeling. We first verified the accuracy of our approach using a series of known Brd4 BD2 degraders. The calculated binding energy showed a good correlation with the experimental Kd values. The modeling of a unique property, namely, the α value, for PROTACs was also first and accurately performed to our best knowledge. The results also demonstrated the importance of PROTAC-induced protein-protein interactions in its modeling, either qualitatively or quantitatively. Finally, by standing on the success of earlier docking-based approaches, our protocol was also applied as a rescoring function in pose prediction. The results showed a notable improvement in reranking the initial poses generated from a modified Rosetta method, which was reportedly one of the best among a handful of PROTAC modeling approaches available in this field. We hope this work could provide a practical protocol and more insights to study the binding and the design of PROTACs and other protein degraders.

Application of AlphaFold models in evaluating ligandable cysteines across E3 ligases

Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Chemical Proteomics-based Target Prioritization through a Residue Agnostic Ligandability Assessment Platform

E3 ligase ligand optimization of Clinical PROTACs

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones

Current Advances of Small Molecule E3 Ligands for Proteolysis-Targeting Chimeras Design

Optimization of Potent Ligands for the E3 Ligase DCAF15 and Evaluation of Their Use in Heterobifunctional Degraders

In Vivo Target Protein Degradation Induced by PROTACs Based on E3 Ligase DCAF15

A close-up shot of protein-protein docking, from experiment to theory and reverse with the PROTAC performers

Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications

IN SILICO DESIGN AND BINDING MECHANISM OF E3 LIGASE UBR1 RECRUITERS

Computational Strategies for PROTAC Drug Discovery

Importance of Three-Body Problems and Protein-Protein Interactions in Proteolysis-Targeting Chimera Modeling: Insights from Molecular Dynamics Simulations

Targeted protein degradation: expanding the toolbox

E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points

Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)

Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges

Discovery of E3 Ligase Ligands for Target Protein Degradation

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras